Completed Infection & Immunity Cells, Biochemistry & Physiology

Structural studies of host-parasite interactions at the heart of malaria pathogenicity.

In plain English

AI plain-English summary

Malaria parasites use specific surface proteins to latch onto human cells, and this project will map those molecular handshakes in atomic detail. The problem is that malaria parasites are masters of disguise—they constantly change their surface proteins to evade the immune system, while still needing to bind to human receptors to survive and cause disease. Vaccine developers need to know which parts of these proteins are essential and unchanging, so they can train the immune system to attack those vulnerable spots. This research will determine the three-dimensional structures of three critical interactions: how *P. falciparum* invades red blood cells via the Rh5-basigin pairing, how *P. vivax* does the same through DBP-DARC, and how VAR2CSA anchors infected cells in the placenta during pregnancy-associated malaria. The team will also raise and structurally characterise inhibitory antibodies that block these interactions. If successful, the work will provide precise blueprints for designing immunogens—molecules that teach the body to produce protective antibodies—guiding the development of vaccines against both major malaria species and pregnancy-associated malaria.

View original technical description
My research will provide molecular insight into interactions that essential cell surface proteins of the malaria parasites make with receptors from their human host or with inhibitory monoclonal antibodies, thereby guiding immunogen design in vaccine development. Surface proteins mediate essential steps in the parasite life cycle, including sequestration from spleenic clearance and host cell invasion. They must balance conflicting selection pressures, maintaining interactions while diversifying to aid immune evasion. Structural studies will allow us to map polymorphisms onto molecular surfaces while identifying conserved binding sites and inhibitory epitopes on which to focus immune recognition. We will target interactions essential to disease, initially characterising the binding of: 1. Rh5 to basigin, essential in red blood cell invasion by P. falciparum. 2. DBP to DARC, essential in red blood cell invasion by P. vivax. 3. VAR2CSA to chondroitin sulphates, essential in place ntal sequestration during pregnancy-associated malaria. In each case we will use the latest tools to determine structures of protein-ligand complexes. In collaboration with colleagues at the Jenner Institute, Oxford and CMP, Copenhagen we will raise inhibitory monoclonal antibodies and structurally characterise inhibitory epitopes. This will provide detailed molecular insight to guide the selection or engineering of immunogens that will induce protective immunity against malaria.

View the original record at the funder ↗

Researchers

Matthew Higgins (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Erythrocyte invasion in malaria: molecular mechanism to precision therapeutics
Structural studies of Plasmodium PIR proteins and their interactions with human inhibitory immune receptors
Functional genomics of malaria sporozoite - host hepatocyte interactions
Virulence gene dynamics in the human malaria parasite.
A comprehensive survey of protein-protein interactions between Plasmodium falciparum merozoites and human receptors

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.